Cidara Therapeutics(CDTX) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results SAN DIEGO, May 8, 2025 — Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) therapeutics, today reported financial results for the first quarter ended March 31, 2025, and provided recent business updates. ® "Coinciding with the end of the 2024-2025 flu season in the Northern Hemisphere, we have es ...